A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer (ROSELLA)

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Highlands Ranch Hospital
University of Colorado Hospital

Principal Investigator
Photograph of Bradley Corr,  MD

Bradley Corr, MD

Study ID

Protocol Number: 22-1449

More information available at ClinicalTrials.gov: NCT05257408

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers